Sotera Health Co
NASDAQ:SHC

Watchlist Manager
Sotera Health Co Logo
Sotera Health Co
NASDAQ:SHC
Watchlist
Price: 12.95 USD -2.63%
Market Cap: 3.7B USD
Have any thoughts about
Sotera Health Co?
Write Note

Sotera Health Co
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sotera Health Co
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Sotera Health Co
NASDAQ:SHC
Long-Term Debt
$2.3B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Long-Term Debt
$31.2B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
11%
Danaher Corp
NYSE:DHR
Long-Term Debt
$16.3B
CAGR 3-Years
-12%
CAGR 5-Years
0%
CAGR 10-Years
19%
Mettler-Toledo International Inc
NYSE:MTD
Long-Term Debt
$1.9B
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
18%
Agilent Technologies Inc
NYSE:A
Long-Term Debt
$2.1B
CAGR 3-Years
-8%
CAGR 5-Years
11%
CAGR 10-Years
0%
IQVIA Holdings Inc
NYSE:IQV
Long-Term Debt
$12.3B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
20%
No Stocks Found

Sotera Health Co
Glance View

Market Cap
3.7B USD
Industry
Life Sciences Tools & Services

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The firm operates through three segments: Sterigenics, Nordion and Nelson Labs. The Sterilization Services includes products, such as procedure kits and trays, implants, syringes, catheters, wound care products, medical protective barriers, including personal protective equipment (PPE), laboratory products and pharmaceuticals. Its lab testing and advisory services offer microbiological and analytical chemistry laboratory tests across the medical device and pharmaceutical industries. Its medical device testing services include microbiology, biocompatibility and toxicology assessments, material characterization, sterilization validation, sterility assurance. Its pharmaceutical lab testing services include microbiology, biocompatibility and toxicology assessments, extractables and leachables evaluations of pharmaceutical containers.

SHC Intrinsic Value
21.04 USD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Sotera Health Co's Long-Term Debt?
Long-Term Debt
2.3B USD

Based on the financial report for Dec 31, 2023, Sotera Health Co's Long-Term Debt amounts to 2.3B USD.

What is Sotera Health Co's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
1%

Over the last year, the Long-Term Debt growth was 27%. The average annual Long-Term Debt growth rates for Sotera Health Co have been 7% over the past three years , 1% over the past five years .

Back to Top